INTRODUCTION {#sec1-1}
============

The recent literature reveals that the quinazolinone moiety associated with various aromatic as well heterocyclic compounds possess wide range of pharmacological properties such as antibacterial,\[[@CIT1]\] antifungal,\[[@CIT1]\] analgesic,\[[@CIT2]\] anti-inflammatory,\[[@CIT3]\] anthelminthic,\[[@CIT4]\] anticonvulsant,\[[@CIT5]\] anti HIV,\[[@CIT6]\] antitubercular,\[[@CIT7]\] CNS depressant,\[[@CIT8]\] cytotoxicity,\[[@CIT9]\] diuretic,\[[@CIT10]\] and hypolipidemic\[[@CIT11]\] activities. Pyrazoline systems are known to be biologically active and are important constituents of many pharmacological products. These compounds are known for their antibacterial,\[[@CIT12]\] antifungal,\[[@CIT13]\] antimycobacterial,\[[@CIT14]\] analgesic,\[[@CIT15]\] anti-inflammatory,\[[@CIT16]\] anticancer,\[[@CIT17]\] antiamoebic,\[[@CIT18]\] molluscicidal,\[[@CIT19]\] hypotensive,\[[@CIT20]\] antinociceptive,\[[@CIT21]\] antidepressant,\[[@CIT22]\] anticonvulsant,\[[@CIT23]\] and antiviral\[[@CIT24]\] activities. The aim of the present work was to attach pyrazoline molecule to quinazolin-4(3H)one in order to find new biologically active pharmacophore. Thus, synthesis of pyrazolyl-quinazolin-4(3H)ones 6a-m has been achieved. The potency\[[@CIT25]\] of compounds 6a-m is compared with standard drugs to study the strength of compounds 6a-m, with a hope to get a better antimicrobial agent.

MATERIALS AND METHODS {#sec1-2}
=====================

The melting points were determined in open capillary tubes and are uncorrected. The infrared (IR) spectra of the synthesized compounds were recorded using KBr pellet on Perkin Elmer 1300 FTIR spectrometer and frequencies are recorded in wave number (cm^-1^). Nuclear magnetic resonance (^1^H-NMR and ^13^C-NMR) spectra were recorded on Bruker Avance II 400 NMR spectrometer using deutero chloroform (CDCl~3~) as a solvent. The chemical shifts are reported in δ (part per million) downfield from tetramethylsilane (TMS) as an internal standard. The purity of all the compounds was checked by TLC on Merck silica gel 60 F254 using toluene:ethylacetate (8:2) as mobile phase, and spots were visualized under UV radiation. 2-\[(2,6-Dichlorophenyl)amino\]phenyl acetyl chloride 1 was synthesized by the literature procedure.\[[@CIT26]\]

Procedure for the preparation of 2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-6,8-dibromo-3,1-benzoxazin-4(H)one (2)

A mixture of 2-\[(2,6-dichlorophenyl)amino\]phenyl acetyl chloride 1 (0.01 mol) and 3,5-dibromo anthranilic acid (0.01 mol) in 20 ml pyridine was stirred at 0-5 °C for 1 h, further stirred for 1 h at room temperature. After completion of reaction, a pasty mass obtained and was washed thoroughly with sodium bicarbonate (5 % w/v) to remove unreacted acid. A solid separated was filtered, dried, and recrystallized from methanol.

Yield: 68%. m.p. 171-173 °C. IR (KBr) (cm^-1^): 3447 (NH str), 2927, 2854 (CH~2~str), 1748 (C=O str), 1614 (C=N str), 1150 (C-O str), 743 (C-Cl str), 565 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.55 (s, 2H, CH~2~), 6.37-8.15 (m, 9H, Ar-H), 9.13 (bs, 1H, NH). Anal. found: C, 45.36; H, 2.15; N, 5.07 %; Calcd. for C~21~H~12~Br~2~Cl~2~N~2~O~2~, C, 45.44; H, 2.18; N, 5.05 %.

Procedure for the preparation of 3-Amino-2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-6,8-dibromoquinazolin-4(3H)one (3)

A mixture of 2-\[2-(2,6-dichlorophenyl)amino\]benzyl-6,8-dibromo-3,1-benzoxazine-4(H)one 2 (0.01 mol) and hydrazine hydrate (0.01 mol) in 25 ml absolute ethanol was refluxed on water bath for 6-8 h. After completion of the reaction, it was slowly poured onto crushed ice with continuous stirring. The solid thus obtained, was filtered, and washed several times with cold water. The crude product was dried and recrystallized from ethanol.

Yield: 64%. m.p. 146-148 °C. IR (KBr) (cm^-1^): 3510-3393 (NH and NH~2~str), 2932, 2857 (CH~2~str), 1721 (C=O str), 1612 (C=N str), 748 (C-Cl str), 570 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.58 (s, 2H, CH~2~), 5.75 (bs, 2H, NH~2~), 6.38-8.10 (m, 9H, Ar-H), 9.15 (bs, 1H, NH). Anal. found: C, 44.25; H, 2.53; N, 9.81 %; Calcd. for C~21~H~14~Br~2~Cl~2~N~4~O, C, 44.32; H, 2.48; N, 9.85 %.

Procedure for the preparation of 2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-acetamido-6,8-dibromoquinazolin-4(3H)one (4)

To the solution of 3-amino-2-\[2-(2,6-dichlorophenyl)amino\]benzyl-6,8-dibromoquinazolin-4(3*H*)one **3** (0.01 mol) in 50 ml dry benzene, acetyl chloride (0.01 mol) was added drop by drop at 0-5 °C over the period of 1 h with continuous shaking. After completion of the addition, the reaction mixture was kept overnight. The excess of solvent was distilled off under reduced pressure and then poured onto ice and shaken well. The solid thus obtained was filtered and recrystallized from methanol.

Yield: 69 %. m.p. 193-195 °C. IR (KBr) (cm^-1^): 3447 (NH str), 2935, 2859 (CH~2~str), 1727 (C=O str), 1645(C=O str of amide), 1615 (C=N str), 753 (C-Cl str), 573 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 2.23 (s, 3H, CH~3~), 3.53 (s, 2H, CH~2~), 6.37-8.12 (m, 9H, Ar-H), 9.14 (bs, 1H, NH), 10.32 (bs, 1H, NH). Anal. found: C, 45.28; H, 2.61; N, 9.15 %; Calcd. for C~23~H~16~Br~2~Cl~2~N~4~O~2~, C, 45.20; H, 2.64; N, 9.17 %.

General procedure for the preparation of 2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(substituted phenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5a-m)

To the solution of 2-\[2-(2,6-dichlorophenyl)amino\]benzyl-3-acetamido-6,8-dibromoquinazolin-4(3*H*)one **4** (0.01 mol) in 50 ml absolute ethanol, benzaldehyde (0.01 mol) in 2 % NaOH was added and refluxed for 10-12 h. After completed the reaction, it was concentrated, cooled, and poured onto ice. The solid thus obtained was filtered, washed with water, and recrystallized from methanol. The remaining compounds **5b-m** were synthesized by using the same procedure.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(phenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5a)

Yield: 67 %. m.p. 146-148 °C. IR (KBr) (cm^-1^): 3441 (NH str), 2921, 2852 (CH~2~str), 1719 (C=O str), 1613 (C=N str), 1576 (CH=CH str), 749 (C-Cl str), 578 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.56 (s, 2H, CH~2~), 6.39-8.16 (m, 14H, Ar-H), 6.80 (d, 1H, =CHCO, *J* = 16 Hz), 7.62 (d, 1H, =CH-Ar, *J* = 16 Hz), 8.84 (bs, 1H, CONH), 9.18 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.57 (CH~2~), 112.37-148.53 (26C, CH=CH and Ar-C), 162.06 (C=O), 168.25 (C=N), 173.12 (CONH). Anal. found: C, 51.46; H, 2.92; N, 8.04 %; Calcd. for C~30~H~20~Br~2~Cl~2~N~4~O~2~, C, 51.53; H, 2.88; N, 8.01%.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(2-hydroxyphenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5b)

Yield: 72%. m.p. 156-158 °C. IR (KBr) (cm^-1^): 3547 (OH str), 3438 (NH str), 2926, 2854 (CH~2~str), 1722 (C=O str), 1617 (C=N str), 1566 (CH=CH str), 757 (C-Cl str), 573 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.54 (s, 2H, CH~2~), 6.37-8.13 (m, 13H, Ar-H), 6.78 (d, 1H, =CHCO, *J* = 16.2 Hz), 7.59 (d, 1H, =CH-Ar, *J* = 16.2 Hz), 8.82 (bs, 1H, CONH), 9.16 (bs, 1H, NH), 10.36 (bs, 1H, OH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.63 (CH~2~), 112.23-155.67 (26C, CH=CH and Ar-C), 161.82 (C=O), 168.40 (C=N), 173.22 (CONH). Anal. found: C, 50.35; H, 2.86; N, 7.79 %; Calcd. for C~30~H~20~Br~2~Cl~2~N~4~O~3~, C, 50.38; H, 2.82; N, 7.83 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(3-hydroxyphenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5c)

Yield: 66%. m.p. 171-173 °C. IR (KBr) (cm^-1^): 3542 (OH str), 3450 (NH str), 2930, 2855 (CH~2~str), 1726 (C=O str), 1612 (C=N str), 1575 (CH=CH str), 752 (C-Cl str), 580 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.51 (s, 2H, CH~2~), 5.57 (bs, 1H, OH), 6.37-8.14 (m, 13H, Ar-H), 6.80 (d, 1H, =CHCO, *J* = 16.2 Hz), 7.63 (d, 1H, =CH-Ar, *J* = 16.2 Hz), 8.86 (bs, 1H, CONH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.60 (CH~2~), 112.18-159.29 (26C, CH=CH and Ar-C), 162.12 (C=O), 168.17 (C=N), 172.98 (CONH). Anal. found: C, 50.31; H, 2.77; N, 7.88 %; Calcd. for C~30~H~20~Br~2~Cl~2~N~4~O~3~, C, 50.38; H, 2.82; N, 7.83 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(4-hydroxyphenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5d)

Yield: 73 %. m.p. 184-186 °C. IR (KBr) (cm^-1^): 3548 (OH str), 3446 (NH str), 2934, 2853 (CH~2~str), 1720 (C=O str), 1609 (C=N str), 1572 (CH=CH str), 748 (C-Cl str), 581 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.58 (s, 2H, CH~2~), 5.59 (bs, 1H, OH), 6.38-8.12 (m, 13H, Ar-H), 6.81 (d, 1H, =CHCO, *J* = 16.4 Hz), 7.62 (d, 1H, =CH-Ar, *J* = 16.4 Hz), 8.80 (bs, 1H, CONH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.45 (CH~2~), 112.23-157.32 (26C, CH=CH and Ar-C), 161.93 (C=O), 168.03 (C=N), 173.34 (CONH). Anal. found: C, 50.42; H, 2.83; N, 7.76%; Calcd. for C~30~H~20~Br~2~Cl~2~N~4~O~3~, C, 50.38; H, 2.82; N, 7.83%.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(2-chlorophenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5e)

Yield: 72 %. m.p. 145-147 °C. IR (KBr) (cm^-1^): 3444 (NH str), 2922, 2846 (CH~2~str), 1723 (C=O str), 1614 (C=N str), 1578 (CH=CH str), 745 (C-Cl str), 583 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.55 (s, 2H, CH~2~), 6.37-8.13 (m, 13H, Ar-H), 6.78 (d, 1H, =CHCO, *J* = 16.4 Hz), 7.61 (d, 1H, =CH-Ar, *J* = 16.4 Hz), 8.81 (bs, 1H, CONH), 9.13 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.26 (CH~2~), 111.95-148.49 (26C, CH=CH and Ar-C), 162.02 (C=O), 168.18 (C=N), 173.27 (CONH). Anal. found: C, 49.20; H, 2.67; N, 7.61 %; Calcd. for C~30~H~19~Br~2~Cl~3~N~4~O~2~, C, 49.11; H, 2.61; N, 7.64 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(3-chlorophenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5f)

Yield: 65 %. m.p. 163-165 °C. IR (KBr) (cm^-1^): 3451 (NH str), 2926, 2849 (CH~2~str), 1718 (C=O str), 1611 (C=N str), 1580 (CH=CH str), 755 (C-Cl str), 580 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.52 (s, 2H, CH~2~), 6.38-8.15 (m, 13H, Ar-H), 6.82 (d, 1H, =CHCO, *J* = 16.2 Hz), 7.60 (d, 1H, =CH-Ar, *J* = 16.2 Hz), 8.79 (bs, 1H, CONH), 9.16 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.42 (CH~2~), 112.08-148.36 (26C, CH=CH and Ar-C), 161.87 (C=O), 167.92 (C=N), 173.14 (CONH). Anal. found: C, 49.06; H, 2.57; N, 7.68 %; Calcd. for C~30~H~19~Br~2~Cl~3~N~4~O~2~, C, 49.11; H, 2.61; N, 7.64 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(4-chlorophenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5g)

Yield: 69 %. m.p. 176-178 °C. IR (KBr) (cm^-1^): 3447 (NH str), 2930, 2855 (CH~2~str), 1716 (C=O str), 1610 (C=N str), 1576 (CH=CH str), 744 (C-Cl str), 571 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.58 (s, 2H, CH~2~), 6.37-8.13 (m, 13H, Ar-H), 6.84 (d, 1H, =CHCO, *J* = 16 Hz), 7.60 (d, 1H, =CH-Ar, *J* = 16 Hz), 8.82 (bs, 1H, CONH), 9.17 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.55 (CH~2~), 112.12-148.59 (26C, CH=CH and Ar-C), 162.14 (C=O), 167.88 (C=N), 173.03 (CONH). Anal. found: C, 49.17; H, 2.65; N, 7.58 %; Calcd. for C~30~H~19~Br~2~Cl~3~N~4~O~2~, C, 49.11; H, 2.61; N, 7.64 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(2-nitrophenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5h)

Yield: 70%. m.p. 202-204°C. IR (KBr) (cm^-1^): 3454 (NH str), 2932, 2856 (CH~2~str), 1723 (C=O str), 1615 (C=N str), 1582 (CH=CH str), 1544, 1361 (NO~2~str), 745 (C-Cl str), 577 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.54 (s, 2H, CH~2~), 6.38-8.16 (m, 13H, Ar-H), 6.83 (d, 1H, =CHCO, *J* = 16.2 Hz), 7.62 (d, 1H, =CH-Ar, *J* = 16.2 Hz), 8.81 (bs, 1H, CONH), 9.16 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.38 (CH~2~), 112.06-150.29 (26C, CH=CH and Ar-C), 162.25 (C=O), 168.04 (C=N), 172.91 (CONH). Anal. found: C, 48.36; H, 2.52; N, 9.46%; Calcd. for C~30~H~19~Br~2~Cl~2~N~5~O~4~, C, 48.42; H, 2.57; N, 9.41%.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(3-nitrophenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5i)

Yield: 68%. m.p. 227-229°C. IR (KBr) (cm^-1^): 3453 (NH str), 2930, 2856 (CH~2~str), 1722 (C=O str), 1606 (C=N str), 1576 (CH=CH str), 1538, 1356 (NO~2~str), 741 (C-Cl str), 573 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.52 (s, 2H, CH~2~), 6.37-8.40 (m, 13H, Ar-H), 6.82 (d, 1H, =CHCO, *J* = 16 Hz), 7.64 (d, 1H, =CH-Ar, *J* = 16 Hz), 8.84 (bs, 1H, CONH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.35 (CH~2~), 112.23-150.44 (26C, CH=CH and Ar-C), 161.98 (C=O), 168.28 (C=N), 172.84 (CONH). Anal. found: C, 48.34; H, 2.60; N, 9.43%; Calcd. for C~30~H~19~Br~2~Cl~2~N~5~O~4~, C, 48.42; H, 2.57; N, 9.41%.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(4-nitrophenylacrylamido)-6,8-dibromoquinazolin-4(3H)ones (5j)

Yield: 63%. m.p. 238-239°C. IR (KBr) (cm^-1^): 3446 (NH str), 2932, 2857 (CH~2~str), 1726 (C=O str), 1608 (C=N str), 1585 (CH=CH str), 1543, 1362 (NO~2~str), 756 (C-Cl str), 582 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.58 (s, 2H, CH~2~), 6.38-8.16 (m, 13H, Ar-H), 6.80 (d, 1H, =CHCO, *J* = 16.2 Hz), 7.61 (d, 1H, =CH-Ar, *J* = 16.2 Hz), 8.82 (bs, 1H, CONH), 9.16 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.57 (CH~2~), 112.18-148.24 (26C, CH=CH and Ar-C), 162.21 (C=O), 168.07 (C=N), 173.22 (CONH). Anal. found: C, 48.49; H, 2.51; N, 9.37%; Calcd. for C~30~H~19~Br~2~Cl~2~N~5~O~4~, C, 48.42; H, 2.57; N, 9.41%.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(4-dimethylaminophenylacrylamido)-6,8-dibromo quinazolin-4(3H)ones (5k)

Yield: 67%. m.p. 161-163 °C. IR (KBr) (cm^-1^): 3448 (NH str), 2933, 2858 (CH~2~str), 1718 (C=O str), 1612 (C=N str), 1579 (CH=CH str), 752 (C-Cl str), 578 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 2.84 (s, 6H, N(CH~3~)~2~), 3.55 (s, 2H, CH~2~), 6.37-8.15 (m, 13H, Ar-H), 6.78 (d, 1H, =CHCO, *J* = 16.4 Hz), 7.59 (d, 1H, =CH-Ar, *J* = 16.4 Hz), 8.78 (bs, 1H, CONH), 9.13 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.27 (CH~2~), 46.64 (N-(CH~3~)~2~), 111.92-150.13 (26C, CH=CH and Ar-C), 162.14 (C=O), 168.12 (C=N), 173.06 (CONH). Anal. found: C, 51.67; H, 3.32; N, 9.47%; Calcd. for C~32~H~25~Br~2~Cl~2~N~5~O~2~, C, 51.78; H, 3.39; N, 9.43%.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(2-methoxyphenylacrylamido)-6,8-dibromo quinazolin-4(3H)ones (5l)

Yield: 65 %. m.p. 157-159 °C. IR (KBr) (cm^-1^): 3453 (NH str), 2928, 2850 (CH~2~str), 1723 (C=O str), 1615 (C=N str), 1580 (CH=CH str), 1245, 1103 (C-O-C str), 751, (C-Cl str), 570 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.52 (s, 2H, CH~2~), 3.65 (s, 3H, OCH~3~), 6.38-8.15 (m, 13H, Ar-H), 6.82 (d, 1H, =CHCO, *J* = 16 Hz), 7.63 (d, 1H, =CH-Ar, *J* = 16 Hz), 8.80 (bs, 1H, CONH), 9.18 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.64 (CH~2~), 61.15 (OCH~3~), 112.23-156.34 (26C, CH=CH and Ar-C), 162.26 (C=O), 167.79 (C=N), 173.35 (CONH). Anal. found: C, 50.92; H, 3.10; N, 7.62 %; Calcd. for C~31~H~22~Br~2~Cl~2~N~4~O~3~, C, 51.06; H, 3.04; N, 7.68 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(4-methoxyphenylacrylamido)-6,8-dibromo quinazolin-4(3H)ones (5m)

Yield: 68%. m.p. 173-175°C. IR (KBr) (cm^-1^): 3442 (NH str), 2923, 2849 (CH~2~str), 1710 (C=O str), 1609 (C=N str), 1581 (CH=CH str), 1243, 1108 (C-O-C str), 745 (C-Cl str), 569 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.51 (s, 2H, CH~2~), 3.66 (s, 3H, OCH~3~), 6.37-8.16 (m, 13H, Ar-H), 6.80 (d, 1H, =CHCO, *J* = 16.2 Hz), 7.58 (d, 1H, =CH-Ar, *J* = 16.2 Hz), 8.78 (bs, 1H, CONH), 9.16 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.57 (CH~2~), 59.38 (OCH~3~), 111.97-158.29 (26C, CH=CH and Ar-C), 161.97 (C=O), 167.86 (C=N), 173.16 (CONH). Anal. found: C, 51.14; H, 3.01; N, 7.67%; Calcd. for C~31~H~22~Br~2~Cl~2~N~4~O~3~, C, 51.06; H, 3.04; N, 7.68%.

General procedure for the preparation of 2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(5-substituted phenyl-4,5-dihydro-1H-pyrazol-3-yl-amino)-6,8-dibromoquinazolin-4(3H)ones (6a-m)

A mixture of 2-\[2-(2,6-dichlorophenyl)amino\]benzyl-3-(phenylacrylamido)-6,8-dibromo quinazolin-4(3*H*)one **5a** (0.01 mol) and hydrazine hydrate (0.01 mol) in 30 ml absolute methanol was added few drops of glacial acetic acid and refluxed for 8-10 h. After completion of the reaction, excess of solvent was distilled off; the separated solid was filtered, washed with water, and recrystallized from methanol. Similarly other pyrazolyl derivatives **6b-m** were synthesized.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-(5-phenyl-4,5-dihydro-1H-pyrazol-3-yl-amino)-6,8-dibromoquinazolin-4(3H)ones (6a)

Yield: 58 %. m.p. 133-135 °C. IR (KBr) (cm^-1^): 3443 (NH str), 2924, 2853 (CH~2~str), 1727 (C=O str), 1612 (C=N str), 747 (C-Cl str), 575 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.04 (dd, 1H, Ha, *J*~a,b~ = 17.4 Hz, *J*~ax~ = 5.5 Hz), 3.47 (dd, 1H, Hb, *J*~ba~ = 17.4 Hz, *J*~bx~ = 12 Hz), 3.54 (s, 2H, CH~2~), 5.49 (dd, 1H, Hx, *J*~xb~ = 12 Hz, *J*~xa~= 5.5 Hz), 6.38-8.15 (m, 15H, NH and Ar-H), 8.35 (bs, 1H, NH), 9.17 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.46 (CH~2~), 36.42 (CH~2~of pyrazole), 55.57 (CH of pyrazole), 112.43-148.57 (24C, Ar-C), 161.17 (C=N of pyrazole), 162.15 (C=O), 168.34 (C=N). Anal. found: C, 50.46; H, 3.08; N, 11.72 %; Calcd. for C~30~H~22~Br~2~Cl~2~N~6~O, C, 50.52; H, 3.11; N, 11.78 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(2-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6b)

Yield: 62 %. m.p. 149-151 °C. IR (KBr) (cm^-1^): 3543 (OH str), 3440 (NH str), 2927, 2853 (CH~2~str), 1732 (C=O str), 1607 (C=N str), 755 (C-Cl str), 578 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.02 (dd, 1H, Ha, *J*~a,b~= 17.4 Hz, J~ax~= 5.5 Hz), 3.45 (dd, 1H, Hb, *J*~ba~= 17.4 Hz, *J*~bx~= 11.9 Hz), 3.56 (s, 2H, CH~2~), 5.48 (dd, 1H, Hx, *J*~xb~= 11.9 Hz, *J*~xa~= 5.5 Hz), 6.37-8.14 (m, 14H, NH and Ar-H), 8.42 (bs, 1H, NH), 9.15 (bs, 1H, NH), 10.35 (bs, 1H, OH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.60 (CH~2~), 35.41 (CH~2~of pyrazole), 55.65 (CH of pyrazole), 112.19-155.63 (24C, Ar-C), 161.21 (C=N of pyrazole), 161.94 (C=O), 168.29 (C=N). Anal. found: C, 49.38; H, 3.03; N, 11.54 %; Calcd. for C~30~H~22~Br~2~Cl~2~N~6~O~2~, C, 49.41; H, 3.04; N, 11.52 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(3-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6c)

Yield: 67 %. m.p. 162-163 °C. IR (KBr) (cm^-1^): 3540 (OH str), 3453 (NH str), 2928, 2854 (CH~2~str), 1730 (C=O str), 1609 (C=N str), 750 (C-Cl str), 578 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.05 (dd, 1H, Ha, *J*~a,b~= 17.6 Hz, *J*~ax~= 5.4 Hz), 3.46 (dd, 1H, Hb, *J*~ba~= 17.6 Hz, *J*~bx~= 12 Hz), 3.53 (s, 2H, CH~2~), 5.48 (dd, 1H, Hx, *J*~xb~= 12 Hz, *J*~xa~= 5.4 Hz), 5.59 (bs, 1H, OH), 6.37-8.15 (m, 14H, NH and Ar-H), 8.37 (bs, 1H, NH), 9.14 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.48 (CH~2~), 36.53 (CH~2~of pyrazole), 54.98 (CH of pyrazole), 112.23-159.33 (24C, Ar-C), 161.13 (C=N of pyrazole), 162.26 (C=O), 168.09 (C=N). Anal. found: C, 49.33; H, 3.08; N, 11.55 %; Calcd. for C~30~H~22~Br~2~Cl~2~N~6~O~2~, C, 49.41; H, 3.04; N, 11.52 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6d)

Yield: 63 %. m.p. 177-179 °C. IR (KBr) (cm^-1^): 3550 (OH str), 3448 (NH str), 2931, 2852 (CH~2~str), 1725 (C=O str), 1608 (C=N str), 743 (C-Cl str), 583 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.07 (dd, 1H, Ha, *J*~a,b~= 17.4 Hz, *J*~ax~= 5.4 Hz), 3.49 (dd, 1H, Hb, *J*~ba~= 17.4 Hz, *J*~bx~= 11.8 Hz), 3.56 (s, 2H, CH~2~), 5.46 (dd, 1H, Hx, *J*~xb~= 11.8 Hz, *J*~xa~= 5.4 Hz), 5.58 (bs, 1H, OH), 6.37-8.12 (m, 14H, NH and Ar-H), 8.40 (bs, 1H, NH), 9.17 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.39 (CH~2~), 36.51 (CH~2~of pyrazole), 55.62 (CH of pyrazole), 112.18-157.38 (24C, Ar-C), 161.34 (C=N of pyrazole), 162.04 (C=O), 167.97 (C=N). Anal. found: C, 49.46; H, 3.05; N, 11.48 %; Calcd. for C~30~H~22~Br~2~Cl~2~N~6~O~2~, C, 49.41; H, 3.04; N, 11.52 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(2-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6e)

Yield: 59 %. m.p. 143-145 °C. IR (KBr) (cm^-1^): 3442 (NH str), 2924, 2847 (CH~2~str), 1720 (C=O str), 1611 (C=N str), 741 (C-Cl str), 585 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.02 (dd, 1H, Ha, *J*~a,b~= 17.2 Hz, *J*~ax~= 5.5 Hz), 3.46 (dd, 1H, Hb, *J*~ba~= 17.2 Hz, *J*~bx~= 12 Hz), 3.54 (s, 2H, CH~2~), 5.48 (dd, 1H, Hx, *J*~xb~= 12 Hz, *J*~xa~= 5.5 Hz), 6.38-8.14 (m, 14H, NH and Ar-H), 8.38 (bs, 1H, NH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.32 (CH~2~), 36.46 (CH~2~of pyrazole), 55.56 (CH of pyrazole), 112.03-148.57 (24C, Ar-C), 161.25 (C=N of pyrazole), 162.13 (C=O), 168.10 (C=N). Anal. found: C, 48.12; H, 2.81; N, 11.25 %; Calcd. for C~30~H~21~Br~2~Cl~3~N~6~O, C, 48.19; H, 2.83; N, 11.24 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(3-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6f)

Yield: 67 %. m.p. 151-153 °C. IR (KBr) (cm^-1^): 3447 (NH str), 2926, 2850 (CH~2~str), 1723 (C=O str), 1613 (C=N str), 749 (C-Cl str), 579 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.04 (dd, 1H, Ha, *J*~a,b~= 17.4 Hz, *J*~ax~= 5.5 Hz), 3.47 (dd, 1H, Hb, *J*~ba~= 17.4 Hz, *J*~bx~= 11.8 Hz), 3.52 (s, 2H, CH~2~), 5.46 (dd, 1H, Hx, *J*~xb~= 11.8 Hz, *J*~xa~= 5.5 Hz), 6.38-8.15 (m, 14H, NH and Ar-H), 8.40 (bs, 1H, NH), 9.13 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.24 (CH~2~), 36.56 (CH~2~of pyrazole), 55.63 (CH of pyrazole), 112.17-148.66 (24C, Ar-C), 161.20 (C=N of pyrazole), 162.18 (C=O), 168.21 (C=N). Anal. found: C, 48.26; H, 2.79; N, 11.22 %; Calcd. for C~30~H~21~Br~2~Cl~3~N~6~O, C, 48.19; H, 2.83; N, 11.24 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6g)

Yield: 63 %. m.p. 166-168 °C. IR (KBr) (cm^-1^): 3440 (NH str), 2921, 2848 (CH~2~str), 1719 (C=O str), 1608 (C=N str), 743 (C-Cl str), 575 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.06 (dd, 1H, Ha, *J*~a,b~= 17.5 Hz, *J*~ax~= 5.4 Hz), 3.49 (dd, 1H, Hb, *J*~ba~= 17.5 Hz, *J*~bx~= 11.9 Hz), 3.54 (s, 2H, CH~2~), 5.48 (dd, 1H, Hx, *J*~xb~= 11.9 Hz, *J*~xa~= 5.4 Hz), 6.37-8.16 (m, 14H, NH and Ar-H), 8.37 (bs, 1H, NH), 9.14 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.38 (CH~2~), 36.42 (CH~2~of pyrazole), 55.53 (CH of pyrazole), 111.98-148.57 (24C, Ar-C), 161.23 (C=N of pyrazole), 162.29 (C=O), 168.36 (C=N). Anal. found: C, 48.08; H, 2.80; N, 11.28 %; Calcd. for C~30~H~21~Br~2~Cl~3~N~6~O, C, 48.19; H, 2.83; N, 11.24 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(2-nitrophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6h)

Yield: 69 %. m.p. 169-171 °C. IR (KBr) (cm^-1^): 3450 (NH str), 2928, 2852 (CH~2~str), 1725 (C=O str), 1612 (C=N str), 1548, 1363 (NO~2~str), 754 (C-Cl str), 572 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.04 (dd, 1H, Ha, *J*~a,b~= 17.6 Hz, *J*~ax~= 5.5 Hz), 3.47 (dd, 1H, Hb, *J*~ba~= 17.6 Hz, *J*~bx~= 12 Hz), 3.52 (s, 2H, CH~2~), 5.46 (dd, 1H, Hx, *J*~xb~= 12 Hz, *J*~xa~= 5.5 Hz), 6.39-8.16 (m, 14H, NH and Ar-H), 8.41 (bs, 1H, NH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.21 (CH~2~), 36.59 (CH~2~of pyrazole), 55.68 (CH of pyrazole), 112.10-150.38 (24C, Ar-C), 161.12 (C=N of pyrazole), 162.35 (C=O), 168.19 (C=N). Anal. found: C, 47.43; H, 2.75; N, 12.89 %; Calcd. for C~30~H~21~Br~2~Cl~2~N~7~O~3~, C, 47.52; H, 2.79; N, 12.93 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(3-nitrophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6i)

Yield: 61 %. m.p. 187-189 °C. IR (KBr) (cm^-1^): 3455 (NH str), 2930, 2855 (CH~2~str), 1727 (C=O str), 1615 (C=N str), 1542, 1360 (NO~2~str), 750 (C-Cl str), 577 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.02 (dd, 1H, Ha, *J*~a,b~= 17.5 Hz, *J*~ax~= 5.4 Hz), 3.45 (dd, 1H, Hb, *J*~ba~= 17.5 Hz, *J*~bx~= 11.8 Hz), 3.53 (s, 2H, CH~2~), 5.47 (dd, 1H, Hx, *J*~xb~= 11.8 Hz, *J*~xa~= 5.4 Hz), 6.38-8.39 (m, 14H, NH and Ar-H), 8.42 (bs, 1H, NH), 9.17 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.27 (CH~2~), 36.52 (CH~2~of pyrazole), 55.65 (CH of pyrazole), 112.13-150.46 (24C, Ar-C), 161.05 (C=N of pyrazole), 162.23 (C=O), 168.14 (C=N). Anal. found: C, 47.45; H, 2.76; N, 12.92 %; Calcd. for C~30~H~21~Br~2~Cl~2~N~7~O~3~, C, 47.52; H, 2.79; N, 12.93 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(4-nitrophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6j)

Yield: 63 %. m.p. 198-199 °C. IR (KBr) (cm^-1^): 3441 (NH str), 2925, 2852 (CH~2~str), 1729 (C=O str), 1611 (C=N str), 1540, 1363 (NO~2~str), 754 (C-Cl str), 587 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.05 (dd, 1H, Ha, *J*~a,b~= 17.4 Hz, *J*~ax~= 5.4 Hz), 3.48 (dd, 1H, Hb, *J*~ba~= 17.4 Hz, *J*~bx~= 12 Hz), 3.57 (s, 2H, CH~2~), 5.50 (dd, 1H, Hx, *J*~xb~= 12 Hz, *J*~xa~= 5.4 Hz), 6.37-8.15 (m, 14H, NH and Ar-H), 8.40 (bs, 1H, NH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.53 (CH~2~), 36.47 (CH~2~of pyrazole), 55.70 (CH of pyrazole), 112.24-148.39 (24C, Ar-C), 161.17 (C=N of pyrazole), 162.34 (C=O), 168.18 (C=N). Anal. found: C, 47.40; H, 2.80; N, 12.85 %; Calcd. for C~30~H~21~Br~2~Cl~2~N~7~O~3~, C, 47.52; H, 2.79; N, 12.93 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(4-dimethylaminophenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6k)

Yield: 60 %. m.p. 157-159 °C. IR (KBr) (cm^-1^): 3454 (NH str), 2935, 2857 (CH~2~str), 1721 (C=O str), 1616 (C=N str), 758 (C-Cl str), 568 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.06 (dd, 1H, Ha, *J*~a,b~= 17.6 Hz, *J*~ax~= 5.5 Hz), 3.48 (dd, 1H, Hb, *J*~ba~= 17.6 Hz, *J*~bx~= 11.9 Hz), 3.56 (s, 2H, CH~2~), 5.51 (dd, 1H, Hx, *J*~xb~= 11.9 Hz, *J*~xa~= 5.5 Hz), 6.38-8.16 (m, 14H, NH and Ar-H), 8.37 (bs, 1H, NH), 9.14 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.32 (CH~2~), 36.38 (CH~2~of pyrazole), 55.59 (CH of pyrazole), 112.15-150.27 (24C, Ar-C), 161.22 (C=N of pyrazole), 162.28 (C=O), 168.24 (C=N). Anal. found: C, 50.75; H, 3.59; N, 12.98 %; Calcd. for C~32~H~27~Br~2~Cl~2~N~7~O, C, 50.82; H, 3.60; N, 12.96 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6l)

Yield: 63 %. m.p. 147-149 °C. IR (KBr) (cm^-1^): 3440 (NH str), 2920, 2846 (CH~2~str), 1715 (C=O str), 1606 (C=N str), 1248, 1107 (C-O-C str), 759 (C-Cl str), 575 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.02 (dd, 1H, Ha, *J*~a,b~= 17.4 Hz, *J*~ax~= 5.3 Hz), 3.45 (dd, 1H, Hb, *J*~ba~= 17.4 Hz, *J*~bx~= 11.7 Hz), 3.51 (s, 2H, CH~2~), 3.66 (s, 3H, OCH~3~), 5.48 (dd, 1H, Hx, *J*~xb~= 11.7 Hz, *J*~xa~= 5.3 Hz), 6.37-8.15 (m, 14H, NH and Ar-H), 8.38 (bs, 1H, NH), 9.17 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.51 (CH~2~), 36.46 (CH~2~of pyrazole), 55.47 (CH of pyrazole), 112.11-156.26 (24C, Ar-C), 161.12 (C=N of pyrazole), 162.21 (C=O), 167.94 (C=N). Anal. found: C, 50.02; H, 3.21; N, 11.36 %; Calcd. for C~31~H~24~Br~2~Cl~2~N~6~O~2~, C, 50.09; H, 3.25; N, 11.31 %.

2-\[2-(2,6-Dichlorophenyl)amino\]benzyl-3-\[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl-amino\]-6,8-dibromoquinazolin-4(3H)ones (6m)

Yield: 69 %. m.p. 165-167°C. IR (KBr) (cm^-1^): 3437 (NH str), 2918, 2845 (CH~2~str), 1718 (C=O str), 1607 (C=N str), 1238, 1105 (C-O-C str), 737 (C-Cl str), 562 (C-Br str). ^1^H-NMR (CDCl~3~, 400 MHz), δ (ppm): 3.03 (dd, 1H, Ha, *J*~a,b~= 17.5 Hz, *J*~ax~= 5.5 Hz), 3.46 (dd, 1H, Hb, *J*~ba~= 17.5 Hz, *J*~bx~= 11.8 Hz), 3.52 (s, 2H, CH~2~), 3.64 (s, 3H, OCH~3~), 5.49 (dd, 1H, Hx, *J*~xb~= 11.8 Hz, *J*~xa~= 5.5 Hz), 6.36-8.16 (m, 14H, NH and Ar-H), 8.42 (bs, 1H, NH), 9.15 (bs, 1H, NH). ^13^C-NMR (CDCl~3~, 100 MHz), δ (ppm): 30.64 (CH~2~), 36.40 (CH~2~of pyrazole), 55.42 (CH of pyrazole), 111.85-158.32 (24C, Ar-C), 160.97 (C=N of pyrazole), 162.05 (C=O), 168.02 (C=N). Anal. found: C, 49.96; H, 3.20; N, 11.24 %; Calcd. for C~31~H~24~Br~2~Cl~2~N~6~O~2~, C, 50.09; H, 3.25; N, 11.31 %.

Antimicrobial activity {#sec2-1}
----------------------

The *in vitro* antimicrobial activities of compounds 6a-m were carried out by the cup-plate method.\[[@CIT27]\] Antibacterial activity was screened against two gram-positive bacteria *S. aureus* (ATCC 12228) and B. subtilis (ATCC 11778), and two gram-negative bacteria E. coli (ATCC 8739) and Certium (ATCC 27957), by measuring the zone of inhibition on agar plates at two different concentrations 100 μg/ml and 50 μg/ml. While antifungal activity was tested by measuring the zone of inhibition on agar plates with two fungal species C. albicans (ATCC 10231) and A. niger (ATCC 16404) at two different concentrations 20 μg/ml and 10 μg/ml. Penicillin-G was used as a standard antibacterial agent, whereas fluconazole was used as a standard antifungal agent.

RESULTS AND DISCUSSION {#sec1-3}
======================

The title compounds 2-\[2-(2,6-dichlorophenyl)amino\]benzyl-3-(5-substituted phenyl-4,5-dihydro -1*H*-pyrazol-3-yl-amino)-6,8-dibromoquinazolin-4(3*H*)ones 6a-m were synthesized according to described process in [Scheme 1](#F0001){ref-type="fig"}. The structures of all the synthesized compounds were elucidated by the elemental analysis as well as IR and NMR spectral data. IR spectra showed strong C=O and C=N stretching of quinazolinone at around 1720 cm^-1^and 1610 cm^-1^. The ^1^H NMR spectra of compounds 6a-m indicated that the -CH~2~protons of the pyrazoline ring resonated as a pair of doublet of doublets (Ha and Hb) due to geminal and vicinal coupling. The CH proton appeared as a doublet of doublet (Hx) due to vicinal coupling with the two magnetically nonequivalent protons of methylene group at position 4 of pyrazoline ring. The Ha proton which is *cis* to Hx resonates upfield in the range δ 3.02-3.07 as a doublet of doublet while Hb, the other proton which is *trans* to Hx resonates downfield in the range δ 3.45-3.49 as a doublet of doublet. The Hx proton which is vicinal to two methylene protons (Ha and Hb) resonates as a doublet of doublet in the range δ 5.46-5.51. In ^13^C NMR spectra, signals at around δ 36.5, δ 55.5, and δ 161 confirms the presence of CH~2~, CH, and C=N of pyrazoline ring, respectively, whereas C=O and C=N signals of quinazolinone ring are appear at around δ 162 and δ 168, respectively.

![Synthetic route of compounds 6a-m](JYPharm-2-173-g001){#F0001}

The results of antibacterial activity are shown in [Table 1](#T0001){ref-type="table"}. Compounds 6a (R = H) and 6h (R = 2-NO~2~) showed good activities against gram-positive bacteria (70.87% and 63.39% against *S. aureus* respectively; 73.97% and 69.56% against *B. subtilis*, respectively). The remaining compounds showed moderate activities (44.19-55.29%) against gram-positive bacteria as compared to penicillin-G. Compounds containing *para*-substituted hydroxyl, chloro and methoxy groups were found active than *ortho*- and *meta*-substituted compounds while *ortho* substituted nitro compound showed good activity than *meta*- and *para*-substituted nitro compounds against gram-positive bacteria. Compounds 6h (R = 2-NO~2~) and 6i (R = 3-NO~2~) exhibited good activities against gram-negative bacteria (65.04% and 74% against *E. coli*, respectively; 68.97% and 78.63% against *Certium*, respectively). The remaining compounds showed moderate activities (37.98-58.63%) against gram-negative bacteria as compared to penicillin-G. *Meta*-substituted hydroxyl and nitro compounds possessed good activity against gram-negative bacteria as compared to *ortho*- and *para*-substituted compounds. Whereas *ortho*-substituted chloro compound was found good as compared to meta and *para*, and methoxy group containing compounds share an equal activity against gram-negative bacteria *E. coli*. On the other hand, *ortho*-substituted methoxy compound was found good than *para*-substituted compound and *meta*-substituted chloro compound showed lower activity as compared to *ortho*- and *para*-substituted chloro compound against gram-negative bacteria *Certium*. Furthermore, compound 6h (R = 2-NO~2~) was active against all gram positive as well as gram-negative bacteria, while compound 6a (R = H) was active against both gram-positive bacteria and compound 6i (R = 3-NO~2~) was active against both gram-negative bacteria. Also, compound 6l (R = 2-OCH~3~) displayed good activity (61.15 %) against gram-negative bacteria *Certium*. In addition compounds containing dimethylamino group exhibited quite low activity than others against gram-positive as well as gram-negative bacteria.

###### 

Antibacterial activity of compounds 6a-m

  Compound     R               Zone of inhibition (mm)                                                              
  ------------ --------------- ------------------------- ---- ------- ---- ---- ------- ---- ---- ------- ---- ---- -------
  6a           H               21                        17   70.87   20   16   73.97   12   10   40.08   11   9    41.85
  6b           2-OH            15                        12   52.83   14   12   50.10   16   13   52.45   15   13   52.40
  6c           3-OH            13                        10   48.23   12   10   44.19   17   14   55.02   16   13   58.22
  6d           4-OH            15                        12   52.83   15   13   53.35   16   13   52.45   15   12   55.43
  6e           2-Cl            13                        10   48.23   12   10   44.19   14   12   44.63   13   11   46.83
  6f           3-Cl            13                        10   48.23   12   10   44.19   12   10   40.08   11   9    41.85
  6g           4-Cl            14                        11   50.47   13   11   47.05   13   11   42.30   13   11   46.83
  6h           2-NO~2~         19                        16   63.39   19   16   69.56   20   16   65.04   19   15   68.97
  6i           3-NO~2~         15                        12   52.83   14   12   50.10   23   19   74.00   22   18   78.63
  6j           4-NO~2~         16                        13   55.29   15   13   53.35   17   14   55.02   16   13   58.22
  6k           4-N(CH~3~)~2~   13                        10   48.23   12   10   44.19   11   9    37.98   10   8    39.56
  6l           2-OCH~3~        14                        11   50.47   13   11   47.05   18   15   57.71   17   14   61.15
  6m           4-OCH~3~        15                        12   52.83   14   12   50.10   18   15   57.71   17   15   58.63
  Penicillin                   30                        25   100     27   21   100     31   25   100     28   23   100

C~H~ = zone of inhibition at 100 μg/ml

C~L~ = zone of inhibition at 50 μg/ml

Pot. = potency in %

The results of antifungal activity are shown in [Table 2](#T0002){ref-type="table"}. Compounds 6d (R = 4-OH), 6e (R = 2-Cl), 6f (R = 3-Cl), 6g (R = 4-Cl), and 6h (R = 2-NO~2~) exhibited very good activities (61.84-84.70 %) against *C. albicans* while compounds 6e (R = 2-Cl), 6f (R = 3-Cl), and 6g (R = 4-Cl) possessed very good activities (63.41-78.57 %) against *A. niger* as compared to standard drug fluconazole. The remaining compounds showed moderate activities. Compounds 6e (R = 2-Cl) and 6g (R = 4-Cl) exhibited pronounced activities (84.70 % and 80.77 %) against *C. albicans* among the series. *Ortho*-substituted chloro and nitro compounds showed good activity as compared to *meta*- and *para*-substituted compounds against both *C. albicans* and *A. niger*. On the other hand, para-substituted hydroxyl compound was found good against *C. albicans* as compared to *ortho* and *meta*, while *meta*-substituted hydroxyl compound possessed higher activity against *A. niger* than *ortho*- and *para*-substituted compounds. Both ortho and *para*-substituted methoxy group containing compounds exhibited same activity against *C. albicans* and *A. niger*.

###### 

Antifungal activity of compounds 6a-m

  Compound      R           Zone of inhibition (mm)                          
  ------------- ----------- ------------------------- ---- ------- ---- ---- -------
  6a            H           15                        12   58.63   15   13   51.52
  6b            2-OH        10                        8    41.28   9    7    35.88
  6c            3-OH        7                         0    49.07   6    0    41.30
  6d            4-OH        9                         7    68.84   9    7    35.88
  6e            2-Cl        22                        18   84.70   22   18   78.57
  6f            3-Cl        19                        16   72.59   18   15   63.41
  6g            4-Cl        21                        17   80.77   20   16   71.35
  6h            2-NO2       16                        13   61.84   15   13   51.52
  6i            3-NO2       13                        11   49.57   12   10   43.00
  6j            4-NO2       15                        13   56.01   14   12   48.51
  6k            4-N(CH3)2   15                        13   56.01   15   13   51.52
  6l            2-OCH3      7                         0    49.07   6    0    41.30
  6m            4-OCH3      7                         0    49.07   6    0    41.30
  Fluconazole               26                        21   100     28   22   100

C~H~ = zone of inhibition at 20 μg/ml

C~L~ = zone of inhibition at 10 μg/ml

Pot. = potency in %

CONCLUSIONS {#sec1-4}
===========

All the compounds showed satisfactory elemental as well as IR and NMR spectral results. Compounds bearing 2-nitro group showed promising activity against all bacterial species while chloro group-containing compounds were found active against both fungal species. All this findings give ideas to improve antimicrobial activity for further studies.
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